BioCentury
ARTICLE | Company News

Chiroscience deal

October 10, 1994 7:00 AM UTC

The Cambridge, U.K., company will collaborate with Shire Holdings to develop a synthetic route for the manufacture of galanthamine. Shire will fund Chiroscience's R&D costs and will pay ongoing fees t...